Wednesday, April 22, 2026
29.4 C
Bengaluru

Interview with Ajit Singh, Chairman, ACG

[wpfilebase tag=file id=106 tpl=download-button /]

Inside this Issue

1. Interview with Ajit Singh, Chairman, ACG

Ajit Singh talks to MedicinMan on the key trends and big issues impacting the Indian pharma industry

2. What Does an Ideal, Generics-only Future Look Like? by Rajeev Kumar

An examination of the best possible outcomes of a generics-only future

3. Book Review: Bringing Out the Best in People by Vivek Hattangadi

Using the power of positive reinforcement to bring about lasting behavior change

Download the issue here: PDF

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img